{"DataElement":{"publicId":"6581904","version":"1","preferredName":"Liver Cancer AJCC Edition 8 Clinical Distant Metastasis M Category","preferredDefinition":"Extent of the distant metastasis for hepatocellular carcinoma and fibrolamellar carcinoma based on information obtained from the date of cancer diagnosis until the start of definitive treatment, or within four months (whichever is shorter), using AJCC Ed. 8 criteria.","longName":"LIVR_AJC8_CLN_M_CAT","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"2452422","version":"1","preferredName":"Liver Tumor Clinical M Stage","preferredDefinition":"information related to clinical evaluated M stage of a large organ located in the upper abdomen that cleanses the blood and aids in digestion by secreting bile (the liver).","longName":"LIVER_TUMOR_C_M_S","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"2452420","version":"1","preferredName":"Liver Neoplasm","preferredDefinition":"A large organ located in the upper abdomen. The liver cleanses the blood and aids in digestion by secreting bile.:(NEE-o-PLAY-zha) Abnormal and uncontrolled cell growth.","longName":"C12392:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Liver","conceptCode":"C12392","definition":"A triangular-shaped organ located under the diaphragm in the right hypochondrium. It is the largest internal organ of the body, weighting up to 2 kg. Metabolism and bile secretion are its main functions. It is composed of cells which have the ability to regenerate.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0D51E8D8-64A3-387C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-23","endDate":null,"createdBy":"ALAIS","dateCreated":"2006-02-23","modifiedBy":"ONEDATA","dateModified":"2006-02-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2207806","version":"1","preferredName":"Clinical M Stage","preferredDefinition":"Having to do with the examination and treatment of patients.:One criteria of the TMN staging system.  M refers to the presence of metastasis.","longName":"C25398:C25727","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical","conceptCode":"C25398","definition":"Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"M Category","conceptCode":"C25727","definition":"One criteria of the TNM staging system. M refers to the presence of metastasis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-30E1-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0D51E8D8-64A4-387C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-23","endDate":null,"createdBy":"ALAIS","dateCreated":"2006-02-23","modifiedBy":"TAYLORT","dateModified":"2018-12-19","changeDescription":"12/19/18 TT received CTEP permission/BC to transfer DEC ownership to NCI Standards.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6580738","version":"1","preferredName":"Hepatocellular Carcinoma American Joint Committee on Cancer Edition 8 M Category","preferredDefinition":"A finding about one or more characteristics of hepatocellular carcinoma, following the rules of the TNM AJCC v8 classification system. This staging system applies to hepatocellular carcinomas and fibrolamellar carcinomas (fibrolamellar variant of hepatocellular carcinoma). Intrahepatic cholangiocarcinomas, combined hepatocellular-cholangiocarcinomas, and sarcomas of the liver are not staged using this staging system. (from AJCC 8th Ed.)_A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications._One criteria of the TNM staging system. M refers to the presence of metastasis._A grouping of items based on some commonality or by user defined characteristics.","longName":"6580738v1.0","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"3","maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"pM1","valueDescription":"Hepatocellular Carcinoma pM1 TNM Finding v8","ValueMeaning":{"publicId":"6580740","version":"1","preferredName":"Hepatocellular Carcinoma pM1 TNM Finding v8","longName":"6580740","preferredDefinition":"Hepatocellular carcinoma with distant metastasis. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hepatocellular Carcinoma pM1 TNM Finding v8","conceptCode":"C134467","definition":"Hepatocellular carcinoma with distant metastasis. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C5CD369-8ED6-5DA5-E053-F662850A598F","latestVersionIndicator":"Yes","beginDate":"2018-12-06","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-06","modifiedBy":"ONEDATA","dateModified":"2018-12-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7C5CD369-8EEF-5DA5-E053-F662850A598F","beginDate":"2018-12-06","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-06","modifiedBy":"ONEDATA","dateModified":"2018-12-06","deletedIndicator":"No"},{"value":"cM1","valueDescription":"Hepatocellular Carcinoma cM1 TNM Finding v8","ValueMeaning":{"publicId":"6580742","version":"1","preferredName":"Hepatocellular Carcinoma cM1 TNM Finding v8","longName":"6580742","preferredDefinition":"Hepatocellular carcinoma with distant metastasis. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hepatocellular Carcinoma cM1 TNM Finding v8","conceptCode":"C134462","definition":"Hepatocellular carcinoma with distant metastasis. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C5CD369-8EFC-5DA5-E053-F662850A598F","latestVersionIndicator":"Yes","beginDate":"2018-12-06","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-06","modifiedBy":"ONEDATA","dateModified":"2018-12-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7C5CD369-8F15-5DA5-E053-F662850A598F","beginDate":"2018-12-06","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-06","modifiedBy":"ONEDATA","dateModified":"2018-12-06","deletedIndicator":"No"},{"value":"cM0","valueDescription":"Hepatocellular Carcinoma cM0 TNM Finding v8","ValueMeaning":{"publicId":"6580744","version":"1","preferredName":"Hepatocellular Carcinoma cM0 TNM Finding v8","longName":"6580744","preferredDefinition":"Hepatocellular carcinoma without evidence of distant metastasis. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hepatocellular Carcinoma cM0 TNM Finding v8","conceptCode":"C134461","definition":"Hepatocellular carcinoma without evidence of distant metastasis. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C5CD369-8F22-5DA5-E053-F662850A598F","latestVersionIndicator":"Yes","beginDate":"2018-12-06","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-06","modifiedBy":"ONEDATA","dateModified":"2018-12-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7C5CD369-8F3B-5DA5-E053-F662850A598F","beginDate":"2018-12-06","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-06","modifiedBy":"ONEDATA","dateModified":"2018-12-06","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6580737","version":"1","preferredName":"Hepatocellular Carcinoma TNM Finding v8 American Joint Committee on Cancer M Category Category","preferredDefinition":"A finding about one or more characteristics of hepatocellular carcinoma, following the rules of the TNM AJCC v8 classification system. This staging system applies to hepatocellular carcinomas and fibrolamellar carcinomas (fibrolamellar variant of hepatocellular carcinoma). Intrahepatic cholangiocarcinomas, combined hepatocellular-cholangiocarcinomas, and sarcomas of the liver are not staged using this staging system. (from AJCC 8th Ed.):A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.:One criteria of the TNM staging system. M refers to the presence of metastasis.:A grouping of items based on some commonality or by user defined characteristics.","longName":"C134457:C39315:C25727:C25372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hepatocellular Carcinoma TNM Finding v8","conceptCode":"C134457","definition":"A finding about one or more characteristics of hepatocellular carcinoma, following the rules of the TNM AJCC v8 classification system. This staging system applies to hepatocellular carcinomas and fibrolamellar carcinomas (fibrolamellar variant of hepatocellular carcinoma). Intrahepatic cholangiocarcinomas, combined hepatocellular-cholangiocarcinomas, and sarcomas of the liver are not staged using this staging system. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"American Joint Committee on Cancer","conceptCode":"C39315","definition":"A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"M Category","conceptCode":"C25727","definition":"One criteria of the TNM staging system. M refers to the presence of metastasis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C5CD369-8EA9-5DA5-E053-F662850A598F","latestVersionIndicator":"Yes","beginDate":"2018-12-06","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-06","modifiedBy":"ONEDATA","dateModified":"2018-12-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"7C5CD369-8EBA-5DA5-E053-F662850A598F","latestVersionIndicator":"Yes","beginDate":"2018-12-06","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-06","modifiedBy":"TAYLORT","dateModified":"2019-08-30","changeDescription":"8-20-19 released per MC.; 12/6/18 tmt created for standardization.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5574838","version":"1","longName":"Staging/Extent of Disease","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"6005920","version":"1","longName":"AJCC Edition 8","context":"NCI Standards"},{"publicId":"10000438","version":"1","longName":"Liver","context":"NCI Standards"}]},{"publicId":"6601273","version":"1","longName":"CPTAC (Clinical Proteomic Tumor Analysis Consortium)","context":"OCCPR","ClassificationSchemeItems":[{"publicId":"6776762","version":"1","longName":"Bile duct and Liver","context":"OCCPR"},{"publicId":"6779541","version":"1","longName":"LIHC Baseline","context":"OCCPR"}]}],"AlternateNames":[{"name":"OCCPR","type":"USED_BY","context":"OCCPR"}],"ReferenceDocuments":[{"name":"Clinical M category","type":"Preferred Question Text","description":"Clinical M category","url":null,"context":"NCI Standards"},{"name":"CPTAC-BSLN-1","type":"Alternate Question Text","description":"Clinical Distant Metastasis Status (cM)","url":null,"context":"OCCPR"}],"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"7C60696F-B6CA-66F0-E053-F662850A64D4","latestVersionIndicator":"Yes","beginDate":"2018-12-06","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-06","modifiedBy":"KNABLEJ","dateModified":"2020-02-14","changeDescription":"12/27/19 jk added CPTAC LIHC CSI.  8-30-19 TMT released per MC.; 12/6/18 tmt created for standardization.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}